Lancet Market

Globally, lancets are being utilized by patients who are affected by endocrine related
complications, cardiovascular issues, and many others. Lancets are being used for
diabetes/glucose test, tests in infants, heel-stick screening tests, as well as for scarred
emergency patients or severely burned patients. The Global Lancet Market is growing at an
exponential rate and it is expected to grow at a CAGR of 11.3% during 2016 to 2022.
The increasing prevalence of diabetes and growing incidence number of contagious and noncontagious
diseases has been the major factor for influencing the growth of the market.
Incidence of contagious diseases is increasing rapidly on a global level. According to the
WHO, it has been calculated that, infectious diseases like plaque which is also known as
black death has an estimated 50 million deaths in the 14th century, this infectious disease
can be a serious disease if not treated, this disease has a case fatality ratio of around 30%-
60%, as of 2013 there were 783 cases worldwide which includes 126 deaths.
The Global Lancet Market appears to be oligopolistic owing to the presence of large players
active in the regional market. The market is also characterized by a reasonable degree of
brand loyalty where establishing a brand name is difficult for newcomers. However, the cost
involved in manufacturing setup is low to medium which discreetly comfort the new entrants
to enter in the market easily. Developments in the medical device industry are made to
simplify the diagnosis, prevention, and treatment of various diseases. One of such device is
lancet, which is capturing a huge market share due to its application. Safety lancets and
personal lancets being the two major types of the lancets are dominating the Global Lancet
Market.
Industry Updates
June, 2016: F. Hoffmann-La Roche AG received European approval of Avastin Drug in
combination with Tarceva for cancer patients with a specific type advance lung cancer.
January, 2016: Catalent Inc., a company involved in biologics announced its research
collaboration with Roche on Smartag(TM) technology. Catalent claims Roche will pay
Catalent an up-front fee of $1 million. Roche to provide additional research funding during
the initial phase of the collaboration between these two companies.
October, 2015: BD announced the acquisition of GenCellBio systems, an Irish biotech
company that has developed proprietary technologies that address key biological analysis
protocols, for an undisclosed consideration. The acquisition is expected to improve the BD’s
Next Generation Sequencing line of products.
August, 2015: Roche Holding AG acquired GeneWEAVE to strengthen offerings in
microbiology diagnostics. Roche will pay GeneWEAVE shareholdsers $190 million upfront
and up to $235 million in contingent product related milestones.
March, 2015: BD completed the acquisition of CareFusion Corporation (CareFusion) for
$12.2 billion. CareFusion will operate as a wholly-owned subsidiary of BD. The acquisition is
intended to enhance the medication management and patient safety solutions provided by
BD.
March, 2015: BD announced the acquisition of CRISI Medical Systems, a medical technology
company focused on providing safety and delivery of IV injectable medications. The
acquisition will strengthen BD’s position in addressing preventable medication errors and
improve care delivery efficiencies.
Get Sample Copy at https://www.marketresearchfuture.com/sample_request/2078 .
Global Lancets Market - Competitive Analysis
Many key players involved in this market are keen in introducing new advanced safety
lancets for the treatment of various contagious diseases. HTL-STREFA S.A. accounted for
major market share of global lancet market, with more than 35% of market share. The
large share of the company is attributed to the high demand for safety lancet globally.
Moreover, this company has a strong sales and distribution network and this company also
provides after sales services and help which play a major role in the satisfaction of the
customers. F. Hoffmann-La Roche AG accounts for approximately 22% which can be

attributed to their product the ACCU-CHEK which is one of the safety lancets having high
demand in the market.
The major players in the market which have global operations of the Lancet market, and are
consistently working for the development of the following technology are F. Hoffmann-La
Roche AG, Becton, Dickinson and Company, Greiner Bio One International GmbH, Improve
Medical Technology Co. Ltd, Terumo Medical Corporation, Bayer Cropscience Limited, HTL-
STREFA S.A, Sarstedt AG & Co and others.
Global Lancets Market – Regional Analysis
The oligopolistic nature of the market with North America at its prime holding the largest
regional share. The factors contributing to this major share include the well-established
healthcare infrastructure and the high income generating end users. As of now the medical
device industry is majorly established in the U.S. and Europe. But trends are showing
enormous growth opportunity in Asia, wherein China will play a prominent role in both
usage and development of medical devices.
Moreover, in terms of volume; manufacturers from China are anticipated to capture a large
portion of the market, companies such as Guangzhou IMPROVE MEDICAL Technology Co.
Ltd, SteriLance Medical (Suzhou) Inc., and others are contributing to this major portion.
These companies have established their manufacturing unit worldwide.
Table of Contents
1 Report Prologue
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Global Lancet Market, By Type
7 Global Lancet Market, By End Users
8 Global Lancet Market, By Regions
9 Competitive Landscape
10 Company Profile
11 Bibliography
12 List of Tables
13 List of Figures
Apply for Discount @ https://www.marketresearchfuture.com/check-discount/2078 .
Top Reasons to Buy the Reports:
Company profiling with detailed strategies, financials, and recent development activities
Market Strategic Business Influence Data
Market Research Future recommendations in key business segments based on the
market estimations
Market share analysis of the top industry players
Market forecasts for a minimum of 5 years of all the mentioned segments, Trends and
the regional markets With SWOT Analysis
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and
Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com